Equity Overview
Price & Market Data
Price: $0.0₃1
Daily Change: +$0.0₄99 / 99.00%
Daily Range: $0.0₃1 - $0.0₃1
Market Cap: $11,026
Daily Volume: 1,300
Details
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein, which orchestrates the body's antiviral responses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.